A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Study Identifier
M10-255
CT.gov Identifier
NCT00679731
EudraCT Identifier
2007-004687-47
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
    • Study Drug
  • ABT-874
  • Methotrexate
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of Psoriasis for 6 MO.. BSA 10%, PASI 12 or above, PGA 3 or above
    Exclusion Criteria:
    * Previous exposure to anti-IL 12

    Protocol Summary

    This study is being conducted to compare the efficacy of ABT-874 versus Methotrexate in subjects with moderate to severe plaque psoriasis.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 9904
    Graz, Austria, 8036
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 11001
    Vienna, Austria, 1090
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 12763
    Vienna, Austria, A-1030
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 8022
    Brussels, Belgium, 1200
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 13104
    Barrie, Canada, L4M 6L2
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 13161
    Halifax, Canada, B3H 0A2
    Status
    Not applicable
    Showing {first} - {last} of {total} Results